Launching in 2026, IJTLD Chronic Respiratory Disease (IJTLD CRD) will be open access and fully compliant with Plan S.
Focussing on chronic conditions in low- to middle-income countries, IJTLD CRD will serve a badly neglected area, with an estimated 4 million deaths p.a., and 28–90 million people living with post-TB lung disease (PTLD). Each issue will include a mix of PTLD; COPD; asthma; the impact of air pollution (e.g., biomass burning, vehicle particulates); lung damage in smokers; bronchiectasis; long COVID; and related therapeutic advances.
The journal will publish a broad range of high impact research for the continuing education of academics, clinicians and all other health personnel working on respiratory diseases and lung health, with the aim of improving care, policy and practise.
We invite authors with open access funding to submit their papers (including Editorials, Meeting Reports, Original Articles, Mini Reviews, Perspectives, Case Reports and Letters) to IJTLD CRD.
We welcome submissions on all aspects of the management and care of patients with PTLD; COPD; asthma; the impact of air pollution (e.g., biomass burning, vehicle particulates); lung damage in smokers; bronchiectasis; long COVID and other chronic respiratory diseases.
We are particularly keen to promote the latest therapeutic advances that might have relevance across a range of respiratory conditions.
For all queries please e-mail the Editorial Office
While preparing their article, authors should refer to the Instructions for Authors to check that they have complied with our requirements – see links below.
Once complete, authors should submit their manuscripts at http://mc.manuscriptcentral.com/ijtld
Sponsorship
Supplements and article series are a highly-effective way of highlighting a specific topic to researchers, clinicians and decision makers in respiratory health.
Being an Open Access journal, IJTLD CRD has no barriers to access and can reach readers in health centres, medical, university and pharmaceutical institutes, along with civil society, patients and carers.
All content will be freely available and acknowledge the sponsors support and readers will receive emails to highlight sponsored content.
Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD, IJTLD OPEN and PHA and publishing them in full on our website, prior to their publication in the Journals. Read fast-track articles:
Conflation of prediction and causality in the TB literature
A forthcoming IJTLD OPEN article addresses the frequent conflation of prediction and causal inference in observational TB studies, and outlines practical recommendations to enhance research precision and transparency.
The rationale for cancer to be made a notifiable disease in India
In this Short Communication (to be published in the Q2 issue of PHA), the authors explain why the Ministry of Health in India should make cancer a notifiable disease.
TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe
Ahead of World TB Day, we present an article that assesses the burden of multimorbidity and the effectiveness of referral pathways at the start of TB treatment across Kenya, Uganda, Zambia and Zimbabwe
Evaluating disability, comorbidities and risk factors after TB treatment: an 18–24 month follow-up in China
Ahead of World TB Day, we present an article that assesses disability, comorbidities and risk factors after TB treatment in China.